Evidence map›Paper›PMID 21552561›Full record

ArticlePloS one2011

How much remains undetected? Probability of molecular detection of human Plasmodia in the field.

Cristian Koepfli, Sonja Schoepflin, Michael Bretscher, Enmoore Lin, Benson Kiniboro, Peter A Zimmerman, Peter Siba, Thomas A Smith, Ivo Mueller, Ingrid Felger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Cristian KoepfliSwiss Tropical and Public Health Institute, Basel, Switzerland.
Sonja Schoepflin
Michael Bretscher
Enmoore Lin
Benson Kiniboro
Peter A Zimmerman
Peter Siba
Thomas A Smith
Ivo Mueller
Ingrid Felger
Papua New Guinea Institute of Medical Research · PGSwiss Tropical and Public Health Institute · CHUniversity of Basel · CHCase Western Reserve University · US

Funding

TransmissionU19AI089686 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BURKOT, TOM · 2010 to 2016
$9.9M
Changing Dynamics of Anopheline Transmission of Malaria and Filariasis in Papua nR01TW007872 · FIC · CASE WESTERN RESERVE UNIVERSITY · PI ZIMMERMAN, PETER A. · 2006 to 2010
$2.2M
The effect of mixed Plasmodium infections on morbidityR03AI063135 · NIAID · PAPUA NEW GUINEA INST/ MEDICAL RESEARCH · PI MUELLER, IVO · 2005 to 2006
$103k
FIC NIH HHS R01 TW007872FIC NIH HHS TW007872NIAID NIH HHS AI063135NIAID NIH HHS R03 AI063135NIAID NIH HHS U19 AI089686
6 · The paper itself

Abstract

backgroundIn malaria endemic areas, most people are simultaneously infected with different parasite clones. Detection of individual clones is hampered when their densities fluctuate around the detection limit and, in case of P. falciparum, by sequestration during part of their life cycle. This has important implications for measures of levels of infection or for the outcome of clinical trials. This study aimed at measuring the detectability of individual P. falciparum and P. vivax parasite clones in consecutive samples of the same patient and at investigating the impact of sampling strategies on basic epidemiological measures such as multiplicity of infection (MOI).

methodsSamples were obtained in a repeated cross-sectional field survey in 1 to 4.5 years old children from Papua New Guinea, who were followed up in 2-monthly intervals over 16 months. At each follow-up visit, two consecutive blood samples were collected from each child at intervals of 24 hours. Samples were genotyped for the polymorphic markers msp2 for P. falciparum and msp1F3 and MS16 for P. vivax. Observed prevalence and mean MOI estimated from single samples per host were compared to combined data from sampling twice within 24 h. FINDINGS AND

conclusionEstimated detectability was high in our data set (0.79 [95% CI 0.76-0.82] for P. falciparum and, depending on the marker, 0.61 [0.58-0.63] or 0.73 [0.71-0.75] for P. vivax). When genotyping data from sequential samples, collected 24 hours apart, were combined, the increase in measured prevalence was moderate, 6 to 9% of all infections were missed on a single day. The effect on observed MOI was more pronounced, 18 to 31% of all individual clones were not detected in a single bleed. Repeated sampling revealed little difference between detectability of P. falciparum and P. vivax.

Indexed as

Child, PreschoolCohort StudiesEndemic DiseasesGenotypeHumansInfantPlasmodium falciparumPlasmodium vivaxPolymerase Chain ReactionProbabilityTime Factors

Identifiers

PMID21552561
PMCPMC3084249
OpenAlexW1983196544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.